EBS icon

Emergent Biosolutions
EBS

Overview Fund Activity

134 hedge funds and large institutions have $101M invested in Emergent Biosolutions in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 46 increasing their positions, 44 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
-28
Holders Change %
-17.28%
% of All Funds
1.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
46
Reduced
44
Closed
46
Calls
$443K
Puts
$520K
Net Calls
-$77K
Net Calls Change
+$189K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$5.93M
2
Charles Schwab
2
Charles Schwab
California
$6.9M
3
BlackRock
3
BlackRock
New York
$22.6M
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$2M
5
Qube Research & Technologies (QRT)
5
Qube Research & Technologies (QRT)
United Kingdom
$1.49M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$5.03M
2
Citadel Advisors
2
Citadel Advisors
Florida
$180K
3
Hotchkis & Wiley Capital Management
3
Hotchkis & Wiley Capital Management
California
$3.95M
4
Squarepoint
4
Squarepoint
New York
$190K
5
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$198K
Name Holding Trade Value Shares
Change 		Shares
Change %
FMII
176
Farmers & Merchants Investments Inc
Nebraska
– -$109 -32 Closed
CSPIA
177
Cary Street Partners Investment Advisory
Virginia
– -$17 -5 Closed
4 5 6 7
8